Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote Australian S.E. 08:47:55 28/02/2017 +04 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.7M 2.52M 2.32M 4.34M 294M 4.41M 29.86M 11.69M 146M 11.56M 11.31M 504M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.18M 2.97M 2.73M 5.11M 347M 5.2M 35.18M 13.77M 172M 13.62M 13.33M 594M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 28/01/2020
Director TitleAgeSince
Director/Board Member 60 17/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
+0.14%-0.67%-0.88%+11.02% 47.74B
-2.24%+0.31%+393.45%+615.13% 39.98B
+1.40%+3.69%+12.21%+46.79% 36.23B
+13.94%+20.49%+22.85%+7.42% 35.59B
-0.73%+3.38%+4.94%+41.45% 27.91B
+0.40%-0.30% - - 16.71B
-3.12%+7.39%+26.03%+124.08% 16.45B
+2.39%-1.64%+4.74%+9.95% 13.21B
+6.79%+8.17%-4.97%-28.52% 12.93B
Average +11.90%+12.67%+57.30%+103.42% 24.68B
Weighted average by Cap. +2.10%+2.54%+76.11%+130.59%

Financials

2017 2018
Net sales 16.01K 14.05K 13.08K 12.03K 22.56K 1.53M 22.95K 155K 60.76K 759K 60.1K 58.81K 2.62M 124 108.82 101.34 93.21 174.72 11.85K 177.72 1.2K 470.57 5.88K 465.52 455.46 20.3K
Net income -481K -422K -393K -362K -678K -45.95M -689K -4.66M -1.83M -22.79M -1.81M -1.77M -78.73M -976K -856K -797K -733K -1.37M -93.2M -1.4M -9.46M -3.7M -46.22M -3.66M -3.58M -160M
Net Debt 497K 436K 406K 373K 700K 47.46M 712K 4.82M 1.89M 23.53M 1.86M 1.82M 81.31M 548K 481K 448K 412K 773K 52.38M 786K 5.32M 2.08M 25.98M 2.06M 2.01M 89.76M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-